Evolent Health Inc (NYSE: EVH) stock enjoyed a major increase of 12.8% on 7/16/24. The shares closed at $21.72. Moreover, trading volume in this advance was exceptionally high at 223% of normal. The stock has been extremely weak relative to the market over the last nine months but has risen 10.9% during the last week.
Current PriceTarget Research Rating
EVH’s future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be an important Value Builder.
Evolent Health has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Evolent Health has a slightly positive Appreciation Score of 61 but a poor Power Rating of 29, with the Low Neutral Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment